ISTH-SCC Bleeding Assessment Tool

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

حداقل ۰ — حداکثر ۴ • واحد: points

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
bleeding score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Child - Typical0–2
  • Child - Atypical3–55
  • Adult Male - Typical0–3
  • Adult Male - Atypical4–55
Direct Clinical Answer

The ISTH-SCC Bleeding Assessment Tool calculates assessing bleeding symptoms in patients with inherited bleeding disorders. Key inputs include epistaxis. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Assesses bleeding symptoms in patients with inherited bleeding disorders. This standardized questionnaire was developed by the International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee (SSC) to evaluate 14 different bleeding symptoms and identify patients who may have inherited bleeding disorders requiring further investigation.

Clinical Indication

The ISTH-SCC Bleeding Assessment Tool is indicated for bedside clinical practice to support Assesses bleeding symptoms in patients with inherited bleeding disorders. This standardized questionnaire was developed by the International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee (SSC) to evaluate 14 different bleeding symptoms and identify patients who may have inherited bleeding disorders requiring further investigation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.

Formula & Variables:

Sum of all 14 bleeding variable scores (0-4 points each, except CNS bleeding with 0/3/4 scoring)

Input Parameters

NameTypeRequiredDescription
epistaxisintegerYesNosebleeds - frequency, duration, and severity(points)
cutaneous_bleedingintegerYesSkin bleeding including bruising and petechiae(points)
minor_woundsintegerYesBleeding from minor wounds and cuts(points)
oral_cavityintegerYesBleeding from gums and oral cavity(points)
gi_bleedingintegerYesGastrointestinal bleeding symptoms(points)
hematuriaintegerYesBlood in urine(points)
tooth_extractionintegerYesBleeding after tooth extraction(points)
surgeryintegerYesBleeding after surgical procedures(points)
menorrhagiaintegerYesHeavy menstrual bleeding (applicable to females)(points)
postpartum_hemorrhageintegerYesBleeding after childbirth (applicable to females with delivery history)(points)
muscle_hematomasintegerYesMuscle bleeding and hematomas(points)
hemarthrosisintegerYesJoint bleeding(points)
cns_bleedingstringYesCentral nervous system bleeding (special scoring: never=0, subdural=3, intracerebral=4)(points)
other_bleedingintegerYesOther bleeding symptoms not covered above(points)
age_groupstringYesPatient age group for interpretation thresholds
genderstringYesPatient gender for score interpretation

Score Interpretation & Guidance

RangeStageDescription
0–2Child - TypicalTypical bleeding pattern for children
3–55Child - AtypicalAtypical bleeding pattern for children
0–3Adult Male - TypicalTypical bleeding pattern for adult males
4–55Adult Male - AtypicalAtypical bleeding pattern for adult males
0–5Adult Female - TypicalTypical bleeding pattern for adult females
6–55Adult Female - AtypicalAtypical bleeding pattern for adult females

Evidence-Based References (EBM)

  • Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010 Sep;8(9):2063-5.
  • Elbatarny M, Mollah S, Grabell J, Bae S, Deforest M, Tuttle A, Hopman W, Clark DS, Mauer AC, Bowman M, Riddel J, Christopherson PA, Montgomery RR, James PD. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014 Nov;20(6):831-5.
  • Deforest M, Grabell J, Albert S, Young E, Tuttle A, Hopman WM, Heddle N, James PD. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia. 2015 May;21(3):e132-9.
  • Quiroga T, Goycoolea M, Panes O, Aranda E, Martínez C, Belmont S, Muñoz B, Zúñiga P, Pereira J, Mezzano D. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007 Mar;92(3):357-65.

Related calculators